Garg Pushkal sold ALNY
February 27, 2026 · Form 4 insider transaction
Garg Pushkal sold 140 shares of Alnylam Pharmaceuticals, Inc. at $334.39 per share, a transaction worth $46.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
140
Price
$334.39
Total value
$46.8K
InsiderGarg Pushkal
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 27, 2026
Filing dateMarch 2, 2026
Shares owned after22,129
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 20, 2025.